RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 116 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $8,086 | +20.7% | 5,465,183 | +18.2% | 0.03% | +7.7% |
| Q4 2023 | $6,700 | +33.1% | 4,621,764 | -0.8% | 0.03% | +23.8% |
| Q3 2023 | $5,033 | -14.8% | 4,660,740 | +1.7% | 0.02% | -12.5% |
| Q2 2023 | $5,908 | +20.2% | 4,581,512 | +23.0% | 0.02% | +9.1% |
| Q1 2023 | $4,914 | -7.5% | 3,723,563 | +5.1% | 0.02% | -15.4% |
| Q4 2022 | $5,311 | -99.8% | 3,541,501 | +61.6% | 0.03% | +85.7% |
| Q3 2022 | $2,584,000 | +3.1% | 2,191,861 | -1.2% | 0.01% | +7.7% |
| Q2 2022 | $2,507,000 | +3.2% | 2,218,273 | +172.9% | 0.01% | +30.0% |
| Q1 2022 | $2,429,000 | +56.8% | 812,793 | +38.9% | 0.01% | +66.7% |
| Q4 2021 | $1,549,000 | +160.8% | 585,370 | +245.1% | 0.01% | +200.0% |
| Q4 2020 | $594,000 | -79.5% | 169,635 | -85.9% | 0.00% | -83.3% |
| Q3 2020 | $2,896,000 | +12.1% | 1,206,331 | -14.5% | 0.01% | +9.1% |
| Q2 2020 | $2,583,000 | +26.1% | 1,411,054 | +7.4% | 0.01% | -8.3% |
| Q1 2020 | $2,049,000 | +2.3% | 1,313,532 | +40.4% | 0.01% | +33.3% |
| Q4 2019 | $2,003,000 | +230.5% | 935,631 | +188.7% | 0.01% | +200.0% |
| Q3 2019 | $606,000 | -8.6% | 324,070 | +27.4% | 0.00% | 0.0% |
| Q2 2019 | $663,000 | +556.4% | 254,282 | +548.3% | 0.00% | – |
| Q1 2019 | $101,000 | -79.2% | 39,224 | -70.4% | 0.00% | -100.0% |
| Q3 2016 | $486,000 | +38.5% | 132,479 | -21.6% | 0.00% | 0.0% |
| Q1 2016 | $351,000 | +494.9% | 168,947 | +767.2% | 0.00% | – |
| Q4 2015 | $59,000 | +5800.0% | 19,481 | +4605.6% | 0.00% | – |
| Q3 2015 | $1,000 | -93.8% | 414 | -91.8% | 0.00% | – |
| Q2 2015 | $16,000 | +6.7% | 5,057 | +21.8% | 0.00% | – |
| Q1 2015 | $15,000 | – | 4,153 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.02% |